Serving life sciences companies in relation to all their legal needs, Crefovi represents leading and emerging companies in this broad and rapidly evolving industry.
A strategic counsel
Life sciences companies rely on Crefovi’s unique combination of industry knowledge, legal acumen and strategic business expertise.
With increased regulatory scrutiny, pricing and cost pressures, as well as the rapid developments in genomic technology leading to a more personalised approach to medicine and healthcare, businesses and organisations in the life sciences and healthcare sector face a growing number of complex legal and regulatory challenges in order to stay competitive.
This deep understanding of the global life sciences industry allows Crefovi’s lawyers to offer superior counsel to clients involved in transactions, investigations, litigation, intellectual property matters and regulatory challenges. They understand the economic, market, regulatory and political climates in which life sciences companies operate and integrate these factors when addressing clients’ legal and business needs.
Client-focused representation
The law firm Crefovi represents public and private life sciences companies at all stages of development, from start-up and emerging growth to mature public companies, in the following industries:
- biofuels;
- bioinformatics;
- biotechnology;
- cosmeceuticals;
- diagnostics;
- drug delivery;
- ehealth;
- genomics;
- health care;
- medical devices;
- nanotechnology;
- pharmaceuticals;
- proteomics, and
- therapeutics.
Deep industry knowledge in life sciences
Crefovi’s lawyers work closely with their clients, to address their legal needs and achieve their goals throughout the full life cycle of their companies. Our law firm also serves as company counsel in a range of areas, including:
- corporate structure;
- corporation governance;
- due diligence;
- employee benefits;
- executive compensation, and
- formation.
Lawyers in this group assist clients in raising capital in:
- angel/seed offerings;
- initial public offerings;
- late stage equity offerings;
- private and public debt and equity offerings, and
- venture capital.
The firm’s mergers and acquisitions work in the life sciences industry routinely includes:
- asset and stock acquisitions;
- public and private mergers;
- private equity and leveraged buyouts, and
- antitrust and EU competition.
Crefovi’s regulatory and enforcement work in the life sciences industry covers:
- clinical trial strategy and compliance in Europe;
- EU regulatory;
- fraud and abuse compliance counseling;
- civil and criminal government investigations defense;
- privacy regimes, and European data privacy protection, and
- rules of advertising and co-promotion.
And its technology transactions include:
- asset acquisitions;
- commercial contracts and license agreements;
- commercialisation channel and sales agreements;
- joint ventures;
- outsourcing;
- R&D agreements;
- strategic alliances;
- supply and manufacturing agreements, and
- university licensing.
Finally, Crefovi provides IP counseling and litigation services in areas such as:
- copyrights;
- licensing disputes;
- patent litigation;
- strategic counseling;
- trade secrets, and
- trademarks.
A global network
Clients praise Crefovi’s lawyers for their responsiveness & ability to understand the technical, business and legal aspects of each life sciences transaction and come back, deal after deal, to be advised by them.
While London and Paris based, we routinely work across borders. The vast majority of our engagements are multi-jurisdictional. We are used to working in multinational teams, and rely on our network of specialist lawyers for support in other jurisdictions.
The team has therefore established an extensive international network of life sciences contacts and a close association with other specialist lawyers worldwide. Our history of successes in high profile, politically sensitive matters reflects an ability to act swiftly and with the utmost discretion.
Crefovi regularly updates its social media channels, such as Linkedin, Twitter, Instagram, YouTube and Facebook. Check our latest news there!
